Indatuximab
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Purity
0.9804
Bioactivity
Indatuximab is a chimeric antibody targeting CD13, used in the synthesis of ADC compound Indatuximab ravtansine.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
